ST. MARYS, W.Va., June 8, 2015 /PRNewswire/ -- ProtoKinetix,
Incorporated (OTCQB: PKTX) (the "Company" or "ProtoKinetix")
(www.protokinetix.com) is pleased to announce that ProtoKinetix
began trading today on the OTCQB® Venture Marketplace under the
symbol "PKTX." The Company was formerly trading on the OTC Pink®
marketplace under the same symbol.
U.S. investors can find current financial disclosure and
Real-Time Level 2 quotes for the Company at:
http://www.otcmarkets.com/stock/PKTX/quote.
"After considerable effort and significant investment in our
public disclosure, we are proud to be trading on the OTCQB
marketplace. This upgrade should broaden our shareholder base,
improve liquidity and increase the visibility for our achievements
going forward," said Clarence E.
Smith, President and Chief Executive Officer of
ProtoKinetix.
The OTCQB Venture Marketplace offers transparent trading in
entrepreneurial and development stage U.S. and international
companies. To be eligible, companies must be current in their
financial reporting and must undergo an annual verification and
management certification process. Companies must also meet a
minimum one penny bid test and may not be in bankruptcy.
About
ProtoKinetix
ProtoKinetix, Inc. (OTCQB: PKTX) is a molecular biotechnology
company that has developed and patented a family of hyper stable,
potent glycopeptides (AAGP™) that enhance the therapeutic results
and reduce the cost of stem cell medicine. Due to the
anti-inflammatory effect of AAGP™ molecules, the Company is
currently targeting the direct treatment of diseases that have a
major inflammatory component.
The Private Securities Litigation Reform Act
of 1995 provides a "safe harbor" for forward-looking statements.
Some information included in this press release contains statements
that are forward-looking. Such forward-looking information involves
significant risks and uncertainties that could affect anticipated
results in the future and, accordingly, these results may differ
materially from those expressed in any forward-looking statements
made by or on behalf of the Company. For a description of
additional risks and uncertainties, please refer to the Company's
filings with the Securities and Exchange Commission.
Clarence E. Smith
– President and CEO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/protokinetix-upgrades-to-otcqb-300095226.html
SOURCE ProtoKinetix, Inc.
